Papers
5
Total Citations
42
H-Index
4
About
Louis Surlemont is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for renal cell carcinoma, particularly in complex and elderly patient populations. His major contributions lie in refining robot-assisted partial nephrectomy (RPN) and comparing its outcomes with percutaneous thermal ablation, providing critical evidence for nephron-sparing strategies. His landmark multicenter prospective study (NEPRAH, UroCCR 175, 15 citations) demonstrated that RPN for hilar tumors is safe and effective, with comparable oncologic and functional results to nonhilar masses. Surlemont also developed the Simplified PADUA Renal (SPARE) nephrometry scoring system, showing it accurately predicts renal function outcomes after RPN, making complex surgical planning more accessible. His work on open conversion during minimally invasive renal surgery (UroCCR-135) offers vital predictive factors and management strategies for high-risk cases. Additionally, his ACCURATE trial protocol (2025) pioneers three-dimensional image-guided RPN for complex tumors, setting a new standard for precision surgery. With over 40 citations across his key papers, Surlemont’s research directly shapes clinical guidelines and improves surgical decision-making for renal cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5